These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8108140)

  • 41. Pilocytic astrocytomas do not show most of the genetic changes commonly seen in diffuse astrocytomas.
    Cheng Y; Pang JC; Ng HK; Ding M; Zhang SF; Zheng J; Liu DG; Poon WS
    Histopathology; 2000 Nov; 37(5):437-44. PubMed ID: 11119125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW
    Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Homozygous deletions of the multiple tumor suppressor gene 1 in the progression of human astrocytomas.
    Walker DG; Duan W; Popovic EA; Kaye AH; Tomlinson FH; Lavin M
    Cancer Res; 1995 Jan; 55(1):20-3. PubMed ID: 7805033
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular genetic alterations in radiation-induced astrocytomas.
    Brat DJ; James CD; Jedlicka AE; Connolly DC; Chang E; Castellani RJ; Schmid M; Schiller M; Carson DA; Burger PC
    Am J Pathol; 1999 May; 154(5):1431-8. PubMed ID: 10329596
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of p53 gene mutations in a tumor panel representative of pilocytic astrocytoma diversity using a p53 functional assay.
    Ishii N; Sawamura Y; Tada M; Daub DM; Janzer RC; Meagher-Villemure M; de Tribolet N; Van Meir EG
    Int J Cancer; 1998 Jun; 76(6):797-800. PubMed ID: 9626343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of p53 gene mutations in low- and high-grade astrocytomas by polymerase chain reaction-assisted single-strand conformation polymorphism and immunohistochemistry.
    Koga H; Zhang S; Kumanishi T; Washiyama K; Ichikawa T; Tanaka R; Mukawa J
    Acta Neuropathol; 1994; 87(3):225-32. PubMed ID: 8009954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative study of p53 gene and protein alterations in human astrocytic tumors.
    Louis DN; von Deimling A; Chung RY; Rubio MP; Whaley JM; Eibl RH; Ohgaki H; Wiestler OD; Thor AD; Seizinger BR
    J Neuropathol Exp Neurol; 1993 Jan; 52(1):31-8. PubMed ID: 8381161
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas.
    Willert JR; Daneshvar L; Sheffield VC; Cogen PH
    Genes Chromosomes Cancer; 1995 Mar; 12(3):165-72. PubMed ID: 7536455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
    Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The lack of a role for p53 in astrocytomas in pediatric patients.
    Litofsky NS; Hinton D; Raffel C
    Neurosurgery; 1994 Jun; 34(6):967-72; discussion 972-3. PubMed ID: 8084407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
    Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
    J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression.
    Reifenberger J; Ring GU; Gies U; Cobbers L; Oberstrass J; An HX; Niederacher D; Wechsler W; Reifenberger G
    J Neuropathol Exp Neurol; 1996 Jul; 55(7):822-31. PubMed ID: 8965097
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.
    Leenstra S; Troost D; Westerveld A; Bosch DA; Hulsebos TJ
    Cancer Res; 1992 Mar; 52(6):1568-72. PubMed ID: 1311634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 and PTEN gene mutations in gemistocytic astrocytomas.
    Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
    Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
    Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
    Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Accumulation of wild-type p53 in astrocytomas is associated with increased p21 expression.
    Ono Y; Tamiya T; Ichikawa T; Matsumoto K; Furuta T; Ohmoto T; Akiyama K; Seki S; Ueki K; Louis DN
    Acta Neuropathol; 1997 Jul; 94(1):21-7. PubMed ID: 9224526
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [p53: an important or most overvalued tumor gene?].
    Schlegel U
    Laryngorhinootologie; 1994 Dec; 73(12):651-3. PubMed ID: 7840829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.